Atypical patterns of response and progression in the era of immunotherapy combinations.

Ferrara, Roberto; Matos, Ignacio

Ferrara, Roberto; Matos, Ignacio.

Affiliation

Ferrara R; Department of Research, Molecular Immunology Unit Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Matos I; Department of Medical Oncology, Thoracic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Future Oncol ; 16(23): 1707-1713, 2020 Aug.

Article in En | MEDLINE | ID: mdl-32687405

Subject(s)

Immune Checkpoint Inhibitors/therapeutic use; Immunotherapy/methods; Neoplasms/drug therapy; Neoplasms/pathology; Response Evaluation Criteria in Solid Tumors; Clinical Trials as Topic; Disease Progression; Humans; Neoplasms/immunology; Survival Rate; Treatment Outcome

Key words

combinations; fast progression; hyperprogression disease; immune checkpoint inhibitors; predictive biomarkers; pseudoprogression

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Response Evaluation Criteria in Solid Tumors / Immune Checkpoint Inhibitors / Immunotherapy / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Future Oncol Year: 2020 Document type: Article Affiliation country: Italy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google